Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close

Patient Organisations

Our Commitment to Patient Associations

Up to 3 million people in Europe1 suffer from chronic inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis with the majority of patients reporting that their condition has negatively affected their social and personal life, as revealed in a survey2.

Tillotts is committed to providing assistance beyond medication and supports initiatives organised by patient associations in the Czech Republic, Denmark, Finland, France, Germany, Ireland, Sweden, Switzerland and the United Kingdom, and by the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA).

World IBD Day

On May 19th, World IBD Day, Tillotts supports local initiatives, events and activities to raise awareness of IBD and its impact on patient quality of life. On this day, Tillotts invites all employees and partners to wear the purple ribbon, the symbol of awareness and support for those living with IBD.

World IBD Day banner

Local Initiatives for the World IBD Day

Switzerland – „Welt-CED-Tag“ 2018
More than 25’000 people in Switzerland suffer from IBD. As part of the global World IBD Day awareness campaign, the Swiss Patient Organization SMCCV is organising an event in Solothurn (SO) on May 19th from 9 am to 4 pm where well-known speakers will share their knowledge on IBD. During the art exhibition «My life with IBD», taking place on the same day, patients and relatives will display their paintings depicting how IBD has affected their daily life. Visitors will also have an opportunity to walk through the largest walk-in intestinal model in Europe.

For detailed information on the event, please visit: www.liladarm.ch. Available in German and French only.

For more information on the Swiss Patient Organization SMCCV, please visit: www.smccv.ch. Available in German and French only.

References:
1. Burisch J et al. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013 May;7(4):322-337.
2. Vavricka S, Hofmann R, Guillaume X, et al. prevalence and reasons for drug non-adherence in a European cohort of ulcerative colitis: the UCandME™ survey, Poster P496 presented at the 10th Congress of the European Crohn’s and Colitis Organisation, 2015.